Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis

Trial Profile

Safety and Efficacy of Autologous Adipose Tissue Derived Mesenchymal Stem Cells Transplantation in Patient With Degenerative Arthritis

Completed
Phase of Trial: Phase I/II

Latest Information Update: 28 Jul 2015

At a glance

  • Drugs Mesenchymal stem cell therapy (Primary)
  • Indications Arthritis; Osteoarthritis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors K-STEMCELL
  • Most Recent Events

    • 12 Feb 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top